PharmAla Biotech is a biotechnology company that provides manufacturing and sales of MDMA substances to the clinical research community.
PharmAla Biotech has raised $1.6M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in December 2024.
PharmAla Biotech's investors include Ontario Centre of Innovation.
PharmAla Biotech is headquartered in Toronto, Canada.
PharmAla Biotech is a biotechnology company that provides manufacturing and sales of MDMA substances to the clinical research community.
PharmAla Biotech is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"PharmAla Biotech — Funding & Investors." VCBacked, December 13, 2024, https://www.vcbacked.co/company/pharmala-biotech. Accessed August 17, 2026.
VCBacked. (2024). PharmAla Biotech — Funding & Investors. Retrieved August 17, 2026, from https://www.vcbacked.co/company/pharmala-biotech
{{cite web |title=PharmAla Biotech — Funding & Investors |url=https://www.vcbacked.co/company/pharmala-biotech |website=VCBacked |access-date=August 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated